|
|
 |
|
Viewing report
|
|
|
|
In Vitro Diagnostics Deals: Therapeutic Area Trends
Decision Resources, Inc, Dec 2006, Pages: 27
IVD (in vitro diagnostics) tests are essential to the practice of health care worldwide: an estimated 60-70% of medical decisions involve a diagnostic test. This report focuses on IVD industry deals of the last few years and what they reveal about the current strategies of some of the industry’s larger and smaller companies.
Get the Answers You Need to Shape Your Strategy
Currently, IVD company revenues pale in comparison to those of the larger biopharmaceutical companies, but there are signs of steady growth in this highly segmented market.
What is the value of today’s global IVD market?
How fast is it growing?
Which segments are currently most profitable?
Which are showing strong growth?
Which IVD suppliers accounted for nearly 80% of worldwide sales in 2005?
Several large IVD M&As have occurred in recent years, but licensing deals have been the most common type.
How do licensing deals benefit IVD suppliers?
What do big pharmaceutical and diagnostics companies gain?
Which companies have been most active in M&A and licensing deals?
What does this activity indicate about the future of the IVD industry?
The overall oncology therapeutic area has accounted for the majority of IVD deals to date.
Which oncology segments are most active?
What other therapeutic areas are generating notable deals?
What types of diagnostic assays and tests are most in demand?
Which are being offered as “companion diagnostics” to therapeutic agents?
What new, DNA-based tests are in development?
Scope
The IVD marketplace: Current size, growth, segmentation, disease areas, major and
smaller IVD suppliers, 2005 sales.
IVD mergers and acquisitions: 2005-2006, companies, segments, values, significance.
IVD deals by disease areas: Oncology, cardiovascular, infectious diseases, other therapeutic areas.
IVD deal strategies: Different strategies drive deals in different tiers of the IVD industry.
Future IVD deals: Potential mergers and acquisitions as diagnostics change and the
IVD market continues to grow.
|
|
|
|
